Development of 17alpha-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study (Q36197922)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Development of 17alpha-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study |
scientific article |
Statements
1 reference
Development of 17alpha-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study (English)
1 reference
James A Dykens
1 reference
Walter H Moos
1 reference
Neil Howell
1 reference
1 June 2005
1 reference
1 reference
1052
1 reference
116-135
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference